Figure 2
Kaplan-Meier estimates of relapse-free survival depending on development of differentiation syndrome during induction. (A) In both PETHEMA LPA96 and LPA99 trials; (B) in the PETHEMA LPA 96 trial; (C) in the PETHEMA LPA 99 trial.
Kaplan-Meier estimates of relapse-free survival depending on development of differentiation syndrome during induction. (A) In both PETHEMA LPA96 and LPA99 trials; (B) in the PETHEMA LPA 96 trial; (C) in the PETHEMA LPA 99 trial.
